Two Norwegian patients with melioidosis presenting with bacteraemia and splenic and prostatic abscesses

Journal of Travel Medicine

Volumn 18, Issue 6, 2011, Pages 418-421

  Hesstvedt, Liv ^a   Wilhelmsen, Marianne ^b   Mengshoel, Anne Torunn ^a   Dyrhol Riise, Anne Ma ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DOXYCYCLINE; GENTAMICIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TETRACYCLINE;

ABSCESS; ABSCESS DRAINAGE; ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; MALE; MELIOIDOSIS; MINIMUM INHIBITORY CONCENTRATION; NORWAY; PROSTATE ABSCESS; PROSTATITIS; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN ABSCESS; SPLENECTOMY; TRAVEL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ABSCESS; ADULT; BACTEREMIA; BIOPSY; BURKHOLDERIA PSEUDOMALLEI; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELIOIDOSIS; MIDDLE AGED; NORWAY; PROSTATIC DISEASES; REAL-TIME POLYMERASE CHAIN REACTION; RNA, BACTERIAL; SPLENIC DISEASES; SRI LANKA; THAILAND; TOMOGRAPHY, X-RAY COMPUTED; TRAVEL;

EID: 80054923031     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2011.00550.x     Document Type: Article

References (21)

1. Shih HI, Chuang YC, Cheung BM, et al. Sporadic and outbreak cases of melioidosis in southern Taiwan: clinical features and antimicrobial susceptibility. Infection 2009; 37:9-15.
2. Novak RT, Glass MB, Gee JE, et al. Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J Clin Microbiol 2006; 44:85-90. (Pubitemid 43100584)
3. Cheng AC, Currie BJ. Melioidosis: epidemiology, pathophysiology and management. Clin Microbiol Rev 2005; 18:383-416.
4. Puthucheary SD, Parasakthi N, Lee MK. Septicaemic melioidosis: a review of 50 cases from Malaysia. Trans R Soc Trop Med Hyg 1992; 86:683-685. (Pubitemid 23012937)
5. Lim MK, Tan EH, Soh SC. Burkholderia pseudomallei infection in the Singapore arms forces from 1987- 1994-an epidemiological review. Ann Acad Med Singapore 1997; 26:13-17. (Pubitemid 127518306)
6. Currie BJ, Fisher DA, Howard DM, et al. Endemic melioidosis in tropical northern Australia: a ten year prospective study and review of the literature. Clin Inf Dis 2000; 31:981-986. (Pubitemid 32299357)
7. SvenssonE,Welinder-OlssonC,ClaessonBA, Studahl M. Cutaneous melioidosis in a Swedish tourist after the tsunami in 2004. Scand J Infect Dis 2006; 38:71-74. (Pubitemid 43123849)
8. Nieminen T, Vaara M. Burkholderia pseudomallei infections in Finnish tourists injured by the December 2004 tsunami in Thailand. Euro Surveill 2005; 10:E050303.4.
9. Badran S, Pedersen TI, Roed C, et al. Imported melioidosis in Danish travellers: a diagnostic challenge. Scand J Infect Dis 2010; 42:445-449.
10. Currie BJ, Jacups SP, Cheng AC, et al. Melioidosis epidemiology and risk factors from a prospective wholepopulation study in northern Australia. Trop Med Int Health 2004; 9:1167-1174. (Pubitemid 39573988)
11. Ng CY, Leong EC, Chng HC. Ten-year series of splenic abscesses in a general hospital in Singapore. Ann Acad Med Singapore 2008; 37:749-752.
12. Suputtamongkol Y,Chaowagul W, Chetchotisakd P, et al. Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis 1999; 29:408-413. (Pubitemid 29380208)
13. Holland DJ, Wesley A, Drincovic D, Currie BJ. Cystic fibrosis and Burkholderia pseudomallei infection: an emerging problem ? Clin Infect Dis 2002; 35:e138-e140.
14. Heng BH, Goh KT, Yap EH, et al. Epidemiological surveillance of melioidosis in Singapore. Ann Acad Med Singapore 1998; 27:478-484. (Pubitemid 28457716)
15. Peacock SJ, Schweizer HP,Dance DA, et al. Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis 2008; 14:e2. (Pubitemid 351920471)
16. Lowe P, Haswell H, Lewis K. Use of various common isolation media to evaluate the new VITEK 2 colorimetric GN card for identification of Burkholderia pseudomallei. J Clin Microbiol 2006; 44:854-856.
17. Inglis TJ, Merritt A, Chidlow G, et al. Comparison of diagnostic laboratory methods for identification of Burkholderia pseudomallei. J Clin Microbiol 2005; 43:2201-2206. (Pubitemid 40656227)
18. Lowe P, Engler C, Norton R. Comparison of automated and nonautomated systems for identification of Burkholderia pseudomallei. J Clin Microbiol 2002; 40:4625-4627. (Pubitemid 35434958)
19. Amornchai P, Chierakul W, Wuthiekanun V, et al. Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol 2007; 45:3774-3776. (Pubitemid 350156882)
20. Blaschitz M, Meidlinger L, Sagel U, et al. Detection of highly pathogenic bacteria by MALDI-TOFMS. Abstract P1773. ESCMID 2010.
21. Gee JE, Sacchi CT, Glass MB, et al. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol 2003; 41:4647-4654.